Cryoballoon ablation without use of contrast for the treatment of paroxysmal atrial fibrillation

Background: Cryoballoon ablation (CBA) for atrial fibrillation (AF) is usually preceded by demon- strating pulmonary vein (PV) occlusion using contrast. The aim of the study was to determine efficacy and safety of a simplified protocol for CBA performed without demonstrating PVocclusion and compare achieved results with conventional CBA. Methods: Paroxysmal AF patients undergoing a first-time CBA were prospectively included. In the non-contrast (NC) group CBA was performed using standardized protocol without demonstrating PV occlusion. In the conventional contrast (CC) group ablations were performed after confirmation of PV occlusion. Results: The NC and CC groups comprised 51 and 22 patients, respectively. PVI according to the group assignment was achieved in 34 (67%) and 21 (95.5%) patients from the NC and CC groups, respectively (p < 0.001). In the NC group, 184 (90%) out of204 veins were isolated without venography. There were no differences between the NC and CC groups in terms of procedure duration (89.7 +/- 22.6 vs. 90.0 +/- 20.6 min; p = 0.7) and fluoroscopy time (15.3 +/- 6.3 vs. 15 +/- 4.5 min; p = 0.8). In the NC group, the use of contrast was significantly lower compared to the CC group (4.9 +/- 10.1 vs. 19.4 +/- 8.6 mL, p < 0.001). There were no serious adverse events in both groups. A 1-year freedom from AF was achieved in 73.5% and 71.5% of patients from the NC and CC groups, respectively (p = 1). Conclusions: Cryoballoon ablation without demonstrating vein occlusion with contrast is safe and feasible. Proposed simplified approach enables isolation of the vast majority of pulmonary veins with a significant reduction in the amount of contrast used.